Smith & Nephew
11:57 :
Banks and Smith & Nephew buoy FTSE 100 index -
The top share index recovered ground on Thursday, led by a rebound in heavyweight financial stocks and strong results at medical products group Smith & Nephew , although analysts said Europe's political uncertainty might limit future ...
07:29 :
Patients rank Coloplast as the best company -
In a new global study, patients say that Coloplast has the best customer focus, the most useful products and the strongest patient safety. The study places Coloplast in front of competitors such as Smith & Nephew and Johnson & ...
22:08 :
Pirc recommends voting against Smith & Nephew pay plans -
Some 30% of investors at Smith & Nephew, the medical devices company, failed to endorse its remuneration reportSome 30% of investors at Smith & Nephew, the FTSE-100 medical devices company, failed to endorse ...
01:49 :
S&N pays $22m to settle Greek bribery case -
Smith & Nephew, the
FTSE 100 maker of artificial hips and knees, funnelled £6m through shell companies in the UK to pay bribes to Greek doctors over more than a decade, it was revealed last night.
11:56 :
Smith & Nephew spins off biologics business -
Prosthetics giant Smith & Nephew has announced it will spin off its biologics business into a new US-based joint venture that will be majority owned by private equity firm Essex Woodlands.
08:29 :
Smith & Nephew to spin off biologics unit into JV -
LONDON (Reuters) - Smith & Nephew , Europe's largest artificial hip and knee maker, is to spin off its biologics business into a new joint venture that will be majority owned by international healthcare equity investor Essex Woodlands.
12:15 :
Smith & Nephew lifted by broker upgrade -
Hips-and-knees maker biggest riser on
FTSE after broker upgradeSmith & Nephew, the maker of artificial hips and knees, was the biggest riser on the
FTSE 100 index by late morning, overtaking
ITV, after Exane BNP Paribas|BNP ...
10:15 :
Smith & Nephew slips as figures disappoint and cost cuts loom -
Smith & Nephew hit by poor performance from orthopaedic business, and misses City profit estimatesSmith and Nephew has fallen back after a disappointing trading update, with a poor performance from its orthopaedic division, prompting ...
actualidad Smith & Nephew -